HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.
COVID-19 Drug Development

COVID-19 drug development is a research process to discover a preventative and therapeutic prescription of drugs that would control the severity of coronavirus disease. From 2020 to 2021, various drug companies, biotechnology firms, university research groups, and health organizations were started developing over 600 potential therapies for corona virus disease with various stages of preclinical or clinical research, with 391 therapeutic candidates in clinical trials, as of January 2021.

Committee Members
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - Consolato M Sergi

Consolato M Sergi

University of Ottawa, Canada
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - Sergey Suchkov

Sergey Suchkov

Sechenov University and Moscow Engineering Physical Institute, Russian Federation
Speaker at Pharmaceutics and Novel Drug Delivery Systems 2024 - A C Matin

A C Matin

Stanford University, United States

Submit your abstract Today

Watsapp